Priche Generics Private Limited - Due diligence report
A 360° intelligence report on Priche Generics Private Limited: trust score, financial health, credit view, compliance, directors, growth and…
Priche Generics Private Limited — 360° Intelligence Report
Generated from MCA filings & public recordsPriche Generics Private Limited is assessed as Low Risk with a Trust Score of 83/100. Priche Generics Private Limited is an active private limited indian non-government company incorporated in 2016, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.
Report generated on 13 Jun 2026 from the latest processed filings. Priche Generics Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 3 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- Open charges exceed net worth - secured lenders rank ahead.
- Working-capital cover adequate.
Charges position: 2 open (49.47 cr) · 0 satisfied (-).
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 1 | 48.0 cr |
| Others | 1 | 48.0 cr |
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 1 court forum(s).
- 1 active GST registration(s).
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SUBBARAO KATTAMURI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUSHMA KATTAMURI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- 2 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
As per FY 2019 annual returnPromoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Glochem Industries Private Limited | Holding Company | 74.00% |
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 50 · Distress 90Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- 2 open charge(s) of 49.47 cr already registered.
- Compliance record supports lending.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 9 eventsKey Observations
Auto-generated from the data aboveWho Uses This Report
CA · CS · Banker · Investor · VendorVerify Priche Generics Private Limited before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Priche Generics Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Priche Generics Private Limited - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 83/100, distress signals and MSME payment-delay disclosures - know whether Priche Generics Private Limited pays its suppliers before you extend credit terms.
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Priche Generics Private Limited - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Priche Generics Private Limited an active company?
Priche Generics Private Limited has MCA status “Active” with a compliance score of 93/100 (Low Risk).
Is Priche Generics Private Limited financially healthy?
Priche Generics Private Limited has a Financial Health Score of 65/100 (Moderate) based on its filed financial statements.
Should I do business with Priche Generics Private Limited?
Its overall Trust Score is 83/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Priche Generics Private Limited?
The ultimate holding entity is Glochem Industries Private Limited. 2 active director(s) are on record.
Does Priche Generics Private Limited have loans or charges against its assets?
2 open charge(s) are registered against its assets.
Is Priche Generics Private Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).
Is it risky to lend to Priche Generics Private Limited?
Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.